FindTrial
Sign In

Botulinum toxin injection for failed back surgery syndrome

Lumbar sympathetic block with botulinum toxin type A for failed back surgery syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005659
Enrollment
34
Registered
2020-12-03
Start date
2020-03-01
Completion date
Unknown
Last updated
2021-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Chronic back pain for more than 3 months Patients who had a pain score reduction effect of more than 50% in lumbar sympathetic nerve block surgery using only local anesthetics

Exclusion criteria

Exclusion criteria: IInfection malignancy Bleeding tendency Pregnant, lactating Complex site pain syndrome Patients with spinal cord stimulator or drug injection pump inserted

Design outcomes

Primary

MeasureTime frame
EQ-5D;Numeric rating scale;Oswestry disability index;Leeds Assessment of Neuropathic Symptoms and Signs—

Secondary

MeasureTime frame
Safety assessment—

Countries

Korea, Republic of

Contacts

Public ContactJi Yeong Kim

The Catholic University of Korea, Seoul St. Mary's Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026